Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotics with or without Chinese patent medicine for mixed vaginitis
ChiCTR2200061707Phase 4Not yet recruiting
- Sponsor
- Tianjin Medical University General Hospital
- Start
- Sep 2022
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of cefuroxime axetil, clindamycin and Honghe Fujie Xiye in Aerobic Vaginitis (AV), bacterial vaginosis (BV) and mixed vaginitis (5 arms), sponsored by Tianjin Medical University General Hospital. Primary endpoint: Microscopy-diagnosed AV and BV scores. Planned start Sep 2022; status: not yet recruiting.
02
Drugs
cefuroxime axetilclindamycinHonghe Fujie Xiye
03
Conditions
Aerobic Vaginitis (AV)bacterial vaginosis (BV)mixed vaginitis
Beyond the preview
Go deeper on ChiCTR2200061707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200061707.